Experimental Withdrawal of Lithium in Recovered Manic-Depressive Patients: A Report of Five Cases
Abstract
The authors conducted a single-blind study to determine whether patients with manic-depressive disease who responded favorably to lithium would show significant change when placebo was substituted. Symptoms recurred in all subjects within six weeks of placebo substitution, and clinical stability returned when lithium treatment was resumed. These findings are discussed in relation to the question of the prophylactic influence of long-term maintenance on lithium.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
